The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.
Should artificial intelligence be used in conjunction with Neuroimaging in the diagnosis of Alzheimer’s disease?
Open accessAbstract
Alzheimer’s disease (AD) is a progressive, neurodegenerative disorder that affects memory, thinking, behavior, and other cognitive functions. Although there is no cure, detecting AD early is important for the development of a therapeutic plan and a care plan that may preserve cognitive function and prevent irreversible damage. Neuroimaging, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET), has served as a critical tool in establishing diagnostic indicators of AD during the preclinical stage. However, as neuroimaging technology quickly advances, there is a challenge in analyzing and interpreting vast amounts of brain imaging data. Given these limitations, there is great interest in using artificial Intelligence (AI) to assist in this process. AI introduces limitless possibilities in the future diagnosis of AD, yet there is still resistance from the healthcare community to incorporate AI in the clinical setting. The goal of this review is to answer the question of whether AI should be used in conjunction with neuroimaging in the diagnosis of AD. To answer the question, the possible benefits and disadvantages of AI are discussed. The main advantages of AI are its potential to improve diagnostic accuracy, improve the efficiency in analyzing radiographic data, reduce physician burnout, and advance precision medicine. The disadvantages include generalization and data shortage, lack of in vivo gold standard, skepticism in the medical community, potential for physician bias, and concerns over patient information, privacy, and safety. Although the challenges present fundamental concerns and must be addressed when the time comes, it would be unethical not to use AI if it can improve patient health and outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Current datasets exhibit severe overrepresentation of Caucasian populations”
From Multimodal neuroimaging and AI integration in cognitive disorders: advances, challenges, and future directions for precision medicine (2026) · cites this paper as Mirkin and Albensi, 2023
The cited source says what the claim attributes to it.
In the citing paper
“despite projections that Latino and Black individuals will constitute 40% of USA Alzheimer’s cases by 2030 (Birkenbihl et al., 2020; Mirkin and Albensi, 2023)”
From Multimodal neuroimaging and AI integration in cognitive disorders: advances, challenges, and future directions for precision medicine (2026) · cites this paper as Mirkin and Albensi, 2023
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152
Pearce, M. S., Salotti, J. A., Little, M. P., McHugh, K., Lee, C., Kim, K. P., Howe, N. L., Ronckers, C. M., Rajaraman, P., Craft, A. W., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60815-0 · Cited by 3,735
The neuropathological diagnosis of Alzheimer's disease
DeTure, M. A., & Dickson, D. W. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0333-5 · Cited by 3,329 · cited 1×
“Neuropathologic evidence of extracellular amyloid plaques and intracellular neurofibrillary tangles in a post-mortem analysis remains the only gold standard (DeTure and Dickson, 2019).”
BackgroundAlgorithm aversion: People erroneously avoid algorithms after seeing them err.
Dietvorst, B. J., Simmons, J. P., & Massey, C. (2015) · Journal of Experimental Psychology: General · doi:10.1037/xge0000033 · Cited by 3,232 · cited 1×
“A study found that people are more likely to lose confidence in an algorithm than a human after seeing both make the same mistake, even if the algorithm can outperform a human in certain situations (Dietvorst et al., 2015).”
Background2022 Alzheimer's disease facts and figures
(2022) · Alzheimer's & Dementia · doi:10.1002/alz.12638 · Cited by 2,341
The clinical use of structural MRI in Alzheimer disease
Frisoni, G. B., Fox, N. C., Jack, C. R., Scheltens, P., & Thompson, P. M. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.215 · Cited by 2,113
Precision medicine, AI, and the future of personalized health care
Johnson, K. B., Wei, W., Weeraratne, D., Frisse, M. E., Misulis, K., Rhee, K., Zhao, J., & Snowdon, J. L. (2021) · Clinical and Translational Science · doi:10.1111/cts.12884 · Cited by 1,854
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease
Minoshima, S., Giordani, B., Berent, S., Frey, K. A., Foster, N. L., & Kuhl, D. E. (1997) · Annals of Neurology · doi:10.1002/ana.410420114 · Cited by 1,802
Acosta, J. N., Falcone, G. J., Rajpurkar, P., & Topol, E. J. (2022) · Nature Medicine · doi:10.1038/s41591-022-01981-2 · Cited by 1,365 · cited 1×
“For instance, there is a need for greater external validation of the models, a need for greater quantity and quality of AD data, a need for more diversity, and a need for creating AI models based on multimodal clinical data (Acosta et al., 2022) to help bridge the translational gap.”
Background
Research works printed but not linked: 6
- Alickovic, 2020, For the Alzheimer’s Disease Neuroimaging Initiative, Subasi a. automatic detection of Alzheimer disease based on histogram and random forest, 91
- Neuroimaging Work, 2003, The use of MRI and PET for clinical diagnosis of dementia and investigation of cognitive impairment: a consensus Report
- 2018, Dementia: assessment, management and support for people living with dementia and their carers
- Herring, 2011, Learning radiology: Recognizing the basics E-book
- Kapoor, 2022, PET Scanning. StatPearls
- Ranzenberger, 2022, Diffusion tensor imaging. StatPearls
Cited by
Pathogenesis, diagnostics, and therapeutics for Alzheimer's disease: Breaking the memory barrier
Kamatham, P. T., Shukla, R., Khatri, D. K., & Vora, L. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102481 · Cited by 371
Kale, M., Wankhede, N., Pawar, R., Ballal, S., Kumawat, R., Goswami, M., Khalid, M., Taksande, B., Upaganlawar, A., Umekar, M., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102497 · Cited by 183
Parvin, N., Joo, S., Jung, J. H., & Mandal, T. K. (2025) · Nanomaterials · doi:10.3390/nano15120895 · Cited by 151
The neuroplastic brain: current breakthroughs and emerging frontiers
Gazerani, P. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149643 · Cited by 174
Raza, M. L., Hassan, S. T., Jamil, S., Hyder, N., Batool, K., Walji, S., & Abbas, M. K. (2025) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2025.1557177 · Cited by 74
Metadata
- Authors
- Mirkin, S., & Albensi, B. C.
- Affiliations
- Nova Southeastern University (US)
- Corresponding author
- Mirkin, Sophia
- Albensi, Benedict C.
- Venue
- Frontiers in Aging Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2023-04-18
- Volume
- 15
- Pages
- 1094233-1094233
- ISSN
- 1663-4365 (ISSN-L)
- PMC
- PMC10177660
- OpenAlex
- W4366291948
- Cited by
- 46
- References
- 168
- Citations by year
- 2026: 5 · 2025: 24 · 2024: 14 · 2023: 3
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Aging Neuroscience (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Canadian Institutes of Health Research (162144_1)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
- Keywords
- Alzheimer's disease, artificial intelligence, neuroimaging, early diagnosis, preclinical Alzheimer's disease, magnetic resonance imaging, PET, CT, AI-assisted image analysis, diagnostic accuracy, physician burnout, precision medicine, data scarcity, generalization, physician bias, patient privacy, clinical implementation of AI
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Should artificial intelligence be used in conjunction with Neuroimaging in the diagnosis of Alzheimer’s disease? https://app.cochat.ai/papers/10.3389/fnagi.2023.1094233
- The paper
- Mirkin, S., & Albensi, B. C. (2023). Should artificial intelligence be used in conjunction with Neuroimaging in the diagnosis of Alzheimer’s disease? Frontiers in Aging Neuroscience. https://doi.org/10.3389/fnagi.2023.1094233
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.